CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $525,934 | -52.8% | 31,721 | -47.1% | 0.10% | -63.3% |
| Q4 2022 | $1,114,307 | +19.7% | 59,909 | -17.4% | 0.27% | +25.9% |
| Q3 2022 | $931,000 | -14.0% | 72,562 | -53.0% | 0.21% | -27.1% |
| Q2 2022 | $1,082,000 | -3.6% | 154,367 | +14.0% | 0.29% | -3.6% |
| Q1 2022 | $1,122,000 | +117.4% | 135,381 | +77.7% | 0.30% | +70.6% |
| Q4 2021 | $516,000 | +207.1% | 76,200 | +140.4% | 0.18% | +221.8% |
| Q3 2021 | $168,000 | -32.0% | 31,700 | -26.1% | 0.06% | -46.1% |
| Q2 2021 | $247,000 | – | 42,900 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |